Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.45 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.39 |
| ▸ | CPB2 | Q96IY4 | 4/20 | 0.38 |
| ▸ | GABRR1 | P24046 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | THRB | P10828 | 2/20 | 0.37 |
| ▸ | BLM | P54132 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.37 |
| ▸ | GABRP | O00591 | 1/20 | 0.37 |
| ▸ | GABRD | O14764 | 1/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.37 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.37 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.37 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4955447 | 0.80 | EPHX1 (0.46) | THRBBLM | |
| SCHEMBL1313408 | 0.79 | GGT1 (0.41) | GSRCPB2THRBBLMNFKB1 | |
| SCHEMBL20978334 | 0.74 | — | — | |
| SCHEMBL4949366 | 0.74 | — | — | |
| SCHEMBL28364927 | 0.74 | BHMT (0.48) | GSRLMNAKMT2ACYP1A2GABRP | |
| Hydrochloric Acid SCHEMBL5653794 | 0.74 | EPHX1 (0.44) | GSRRNPEPCPB2GABRR1LMNA | |
| SCHEMBL5969702 | 0.72 | CPB1 (0.56) | GSRRNPEPCPB2GABRR1LMNA | |
| SCHEMBL1681277 | 0.71 | GSR (0.35) | GSRRNPEPCPB2GABRR1LMNA | |
| SCHEMBL11737971 | 0.70 | GSR (0.34) | GSRRNPEPCPB2GABRR1LMNA | |
| SCHEMBL3190291 | 0.70 | GSR (0.34) | GSRRNPEPCPB2GABRR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 505 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12552839-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIROMETIX AG (CH) | 2026-02-17 | — | — | US | claimed |
| US-20260028375-A1 | POLYPEPTIDES SELF-ASSEMBLING INTO NANOPARTICLES | ETH ZUERICH (CH) | 2026-01-29 | — | — | US | claimed |
| EP-3833676-B1 | POLYPEPTIDES SELF-ASSEMBLING INTO NANOPARTICLES | ETH ZUERICH (CH) | 2025-05-28 | — | — | EP | claimed |
| US-20240287143-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Universität Zürich (CH) | 2024-08-29 | — | — | US | claimed |
| EP-4295866-A2 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | Virometix AG (CH) | 2023-12-27 | — | — | EP | claimed |
| EP-3638284-B1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | VIROMETIX AG (CH) | 2023-08-30 | — | — | EP | claimed |
| US-11680085-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIROMETIX AG (CH) | 2023-06-20 | — | — | US | claimed |
| US-11602107-B2 | Graft-mediated hybridisation of monocotyledonous plants | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2023-03-14 | — | — | US | claimed |
| US-20220267379-A1 | NOVEL INHIBITORS OF KALLIKREIN PROTEASES AND USES THEREOF | UNIVERSITÉ PARIS CITÉ (FR) | 2022-08-25 | — | — | US | claimed |
| EP-3999530-A1 | NOVEL INHIBITORS OF KALLIKREIN PROTEASES AND USES THEREOF | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2022-05-25 | — | — | EP | claimed |
| US-20180117082-A1 | ANTIFUNGAL COMPOSITION/TREATMENT | THE UNIVERSITY OF NOTTINGHAM (GB) | 2018-05-03 | — | — | US | claimed |
| EP-3288962-A1 | NOVEL INHIBITORS OF THE ENZYME ACTIVATED FACTOR XII (FXIIA) | Ecole Polytechnique Fédérale de Lausanne (EPFL) (CH) | 2018-03-07 | — | — | EP | claimed |
| EP-3273780-A1 | ANTIFUNGAL COMPOSITION/TREATMENT | The University of Nottingham (GB) | 2018-01-31 | — | — | EP | claimed |
| WO-2017049213-A1 | METHODS AND COMPOSITIONS FOR GENOMIC TARGET ENRICHMENT AND SELECTIVE DNA SEQUENCING | PetaOmics, Inc. (US) | 2017-03-23 | — | — | WO | claimed |
| WO-2016174103-A1 | NOVEL INHIBITORS OF THE ENZYME ACTIVATED FACTOR XII (FXIIA) | Ecole polytechnique fédérale de Lausanne (EPFL) (CH) | 2016-11-03 | — | — | WO | claimed |
| WO-2016151293-A1 | ANTIFUNGAL COMPOSITION/TREATMENT | THE UNIVERSITY OF NOTTINGHAM (GB) | 2016-09-29 | — | — | WO | claimed |
| US-20130225412-A1 | SILICON NANOCARRIER FOR DELIVERY OF DRUG, PESTICIDES AND HERBICIDES , AND FOR WASTE WATER TREATMENT | SARDARI LODRICHE SOROUSH (IR) | 2013-08-29 | — | — | US | claimed |
| EP-1412515-A2 | TREATMENT OF CNS DISORDERS USING D-AMINO ACID OXIDASE AND D-ASPARTATE OXIDASE ANTAGONISTS | Genset (FR) | 2004-04-28 | — | — | EP | claimed |
| WO-2002066672-A2 | TREATMENT OF CNS DISORDERS USING D-AMINO ACID OXIDASE AND D-ASPARTATE OXIDASE ANTAGONISTS | GENSET S.A. (FR) | 2002-08-29 | — | — | WO | claimed |
| US-4401658-A | VACCINE ADJUVANTS, IMMUNOSTIMULANTS | RHONE-POULENC SANTE (FR) | 1983-08-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11680085-B2 | Cyclic peptides for protection against respiratory syncytial virus | VIP, LNPEP, CSTB | GSR 1013/4885RNPEP 12/4885CPB2 174/4885 |
| US-20260028375-A1 | POLYPEPTIDES SELF-ASSEMBLING INTO NANOPARTICLES | PHAX, TPX2, MLX | GSR 2655/4885RNPEP 1698/4885CPB2 4144/4885 |
| US-20240287143-A1 | CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS | VIP, QPCT, QPCTL | GSR 1793/4885RNPEP 580/4885CPB2 1760/4885 |
| US-12552839-B2 | Cyclic peptides for protection against respiratory syncytial virus | CTH, VIP, CXCL10 | GSR 864/4885RNPEP 593/4885CPB2 2020/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.